Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-20-014083
Filing Date
2020-09-30
Accepted
2020-09-30 21:21:55
Documents
1
Period of Report
2020-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160151529655460.html 4  
1 FORM 4 wf-form4_160151529655460.xml 4 5625
  Complete submission text file 0001628280-20-014083.txt   6969
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REVANCE THERAPEUTICS, INC 7555 GATEWAY BLVD NEWARK CA 94560
Business Address
Rankin Aubrey (Reporting) CIK: 0001818576 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 201214074